Tools for studying the regulation of Homer protein splicing

Information

  • Research Project
  • 10349911
  • ApplicationId
    10349911
  • Core Project Number
    R03NS124987
  • Full Project Number
    1R03NS124987-01
  • Serial Number
    124987
  • FOA Number
    PA-20-200
  • Sub Project Id
  • Project Start Date
    9/30/2021 - 2 years ago
  • Project End Date
    2/28/2023 - a year ago
  • Program Officer Name
    CHURN, SEVERN BORDEN
  • Budget Start Date
    9/30/2021 - 2 years ago
  • Budget End Date
    2/28/2023 - a year ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
  • Award Notice Date
    9/24/2021 - 2 years ago

Tools for studying the regulation of Homer protein splicing

Abstract Homer scaffolding proteins are important regulators of glutamatergic synapses that organize metabotropic glutamate receptor (mGluRs 1&5) signaling domains near the post-synaptic density (PSD) where they can induce short and long term synaptic inhibition. Neural activity and other stimuli induce a shift from the constitutively expressed, long Homer1b and 1c isoforms to the immediate early (IEG) Homer1a splice variant. Because Homer1a can interact with binding partners but cannot multimerize to promote scaffolding, it disrupts Homer scaffolds and disperses mGluR1 and 5 from the PSD. Thus, Homer1a acts as a natural dominant negative. Indeed, expression Homer1a can uncouple mGluR1 & 5 from postsynaptic processes such as short and long term depression while protecting mGluR coupling to non-synaptic effectors. By elevating Homer1a expression, cells profoundly change mGluR-effector coupling, acting as a molecular switch for mGluR signaling. In this way, regulation of Homer1 splicing is an important means of altering synaptic ef?cacy. To date however, much remains to be learned about the regulation and expression of Homer1a, including whether Homer1 mRNA splicing and translation occurs locally, near the post-synapse as is the case for many other synaptic proteins. Further, the mechanisms leading to Homer1a splicing are only poorly understood. These questions are relevant not only to the pathophysiological instance in disorders such as epilepsy, but also to the normal physiological situation in which Homer1a is more modestly up, and down regulated in response to more subtle changes in neural ?ring. To this end, we will generate a mouse using CRISPR in which the endogenous Homer1a protein will be C-terminally tagged with a green ?uorescent protein (GFP) and the long isoforms with a red ?uorophore (mScarlet-H) so that their expression levels, time course, and sub-cellular distribution can be analyzed following insult and pharmacological manipulation. These questions and others will bene?t from the animal model we will generate from this proposal. To achieve this, we will pursue the following Speci?c Aims: Aim 1: To optimize and test the differentially tagged long and short Homer proteins in mouse embryonic stem cells. Aim 2: To generate a mouse in which the endogenous short and long Homer proteins are differentially tagged with green (GFP) and red (mScarlet-H) ?orescent proteins.

IC Name
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
  • Activity
    R03
  • Administering IC
    NS
  • Application Type
    1
  • Direct Cost Amount
    100000
  • Indirect Cost Amount
    54000
  • Total Cost
    154000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    853
  • Ed Inst. Type
    SCHOOL OF MEDICINE & DENTISTRY
  • Funding ICs
    NINDS:154000\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    SYN
  • Study Section Name
    Synapses, Cytoskeleton and Trafficking Study Section
  • Organization Name
    UNIVERSITY OF ROCHESTER
  • Organization Department
    PHARMACOLOGY
  • Organization DUNS
    041294109
  • Organization City
    ROCHESTER
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    146270140
  • Organization District
    UNITED STATES